Imilecleucel-T

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameImilecleucel-T
Drug Alias NameAutologous T cell vaccineTovaxinTcelna
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulantsT lymphocytes stimulants
TargetsNot applicable
Therapy Area/IndicationsDisease ProgressionNeuritisPick Disease of the Brain +[7
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesOpexa Therapeutics, Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOpexa Therapeutics, Inc
Active IndicationsN/A
Inactive IndicationsDisease ProgressionNeuritisPick Disease of the Brain +[7

Other Information

ATC CodeN/A
Related LinksKEGG